Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer

Journal of Biological Chemistry

Volumn 288, Issue 4, 2013, Pages 2132-2142

  Esser, Alison K ^a   Miller, Michael R ^a   Huang, Qin ^a   Meier, Melissa M ^a   De Bernabé, Daniel Beltran Valero ^a,b   Stipp, Christopher S ^b,c   Campbell, Kevin P ^a,b,c   Lynch, Charles F ^b,c   Smith, Brian J ^b,c   Cohen, Michael B ^a,c   Henry, Michael D ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PROGRESSION; CELL POLARITY; CELL SURFACE RECEPTORS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX PROTEIN; GLEASON SCORES; HUMAN CANCER; LIGAND BINDING; MOLECULAR MECHANISM; OVER-EXPRESSION; PROSTATE CANCER CELLS; PROSTATE CANCERS; UNDERLYING MECHANISM;

CELL CULTURE; CELL MEMBRANES; ESTERIFICATION; GLYCOSYLATION; TISSUE;

DISEASES;

ALPHA DYSTROGLYCAN; LAMININ; LAMININ 111; LIKE ACETYLGLUCOSAMINYLTRANSFERASE 2; N ACETYLGLUCOSAMINYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GLEASON SCORE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIGAND BINDING; LIKE ACETYLGLUCOSAMINYLTRANSFERASE 2 GENE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; TUMOR GENE;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SEPARATION; DISEASE PROGRESSION; DYSTROGLYCANS; EPITHELIUM; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; IMMUNOHISTOCHEMISTRY; LAMININ; MALE; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING;

EID: 84873831855     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.432807     Document Type: Article

References (60)

1. Ervasti, J. M., Ohlendieck, K., Kahl, S. D., Gaver, M. G., and Campbell, K. P. (1990) Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345, 315-319
2. Ervasti, J. M., and Campbell, K. P. (1991) Membrane organization of the dystrophin-glycoprotein complex. Cell 66, 1121-1131
3. Ibraghimov-Beskrovnaya, O., Ervasti, J. M., Leveille, C. J., Slaughter, C. A., Sernett, S. W., and Campbell, K. P. (1992) Primary structure of dystrophin- associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355, 696-702
4. Ibraghimov-Beskrovnaya, O., Milatovich, A., Ozcelik, T., Yang, B., Koepnick, K., Francke, U., and Campbell, K. P. (1993) Human dystroglycan: skeletal muscle cDNA, genomic structure, origin of tissue specific isoforms and chromosomal localization. Hum Mol. Genet 2, 1651-1657
5. Ervasti, J. M., and Campbell, K. P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J. Cell Biol. 122, 809-823
6. Bowe, M. A., Deyst, K. A., Leszyk, J. D., and Fallon, J. R. (1994) Identification and purification of an agrin receptor from Torpedo postsynaptic membranes: a heteromeric complex related to the dystroglycans. Neuron 12, 1173-1180
7. Campanelli, J. T., Roberds, S. L., Campbell, K. P., and Scheller, R. H. (1994) A role for dystrophin-associated glycoproteins and utrophin in agrin-induced AChR clustering. Cell 77, 663-674
8. Gee, S. H., Montanaro, F., Lindenbaum, M. H., and Carbonetto, S. (1994) Dystroglycan-α, a dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77, 675-686
9. Manya, H., Chiba, A., Yoshida, A., Wang, X., Chiba, Y., Jigami, Y., Margolis, R. U., and Endo, T. (2004) Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc. Natl. Acad. Sci. U.S.A. 101, 500-505
10. Takahashi, T., Honda, R., and Nishikawa, Y. (2000) Cloning of the human cDNA which can complement the defect of the yeast mannosyltransferase I-deficient mutant alg 1. Glycobiology 10, 321-327
11. Aravind, L., and Koonin, E. V. (1999) The fukutin protein family-predicted enzymes modifying cell-surface molecules. Curr. Biol. 9, R836-837
12. Brockington, M., Blake, D. J., Prandini, P., Brown, S. C., Torelli, S., Benson, M. A., Ponting, C. P., Estournet, B., Romero, N. B., Mercuri, E., Voit, T., Sewry, C. A., Guicheney, P., and Muntoni, F. (2001) Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am. J. Hum. Genet. 69, 1198-1209
13. Grewal, P. K., Holzfeind, P. J., Bittner, R. E., and Hewitt, J. E. (2001) Mutant glycosyltransferase and altered glycosylation of α-dystroglycan in the myodystrophy mouse. Nat. Genet. 28, 151-154
14. Hayashi, Y. K., Ogawa, M., Tagawa, K., Noguchi, S., Ishihara, T., Nonaka, I., and Arahata, K. (2001) Selective deficiency of α-dystroglycan in Fukuyama- type congenital muscular dystrophy. Neurology 57, 115-121
15. Hara, Y., Kanagawa, M., Kunz, S., Yoshida-Moriguchi, T., Satz, J. S., Kobayashi, Y. M., Zhu, Z., Burden, S. J., Oldstone, M. B., and Campbell, K. P. (2011) Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection. Proc. Natl. Acad. Sci. U.S.A. 108, 17426-17431
16. Kanagawa, M., Michele, D. E., Satz, J. S., Barresi, R., Kusano, H., Sasaki, T., Timpl, R., Henry, M. D., and Campbell, K. P. (2005) Disruption of perlecan binding and matrix assembly by post-translational or genetic disruption of dystroglycan function. FEBS Lett. 579, 4792-4796
17. Kanagawa, M., Saito, F., Kunz, S., Yoshida-Moriguchi, T., Barresi, R., Kobayashi, Y. M., Muschler, J., Dumanski, J. P., Michele, D. E., Oldstone, M. B., and Campbell, K. P. (2004) Molecular recognition by LARGE is essential for expression of functional dystroglycan. Cell 117, 953-964
18. Michele, D. E., Barresi, R., Kanagawa, M., Saito, F., Cohn, R. D., Satz, J. S., Dollar, J., Nishino, I., Kelley, R. I., Somer, H., Straub, V., Mathews, K. D., Moore, S. A., and Campbell, K. P. (2002) Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies. Nature 418, 417-422
19. Kobayashi, K., Nakahori, Y., Miyake, M., Matsumura, K., Kondo-Iida, E., Nomura, Y., Segawa, M., Yoshioka, M., Saito, K., Osawa, M., Hamano, K., Sakakihara, Y., Nonaka, I., Nakagome, Y., Kanazawa, I., Nakamura, Y., Tokunaga, K., and Toda, T. (1998) An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 394, 388-392
20. Yoshida, A., Kobayashi, K., Manya, H., Taniguchi, K., Kano, H., Mizuno, M., Inazu, T., Mitsuhashi, H., Takahashi, S., Takeuchi, M., Herrmann, R., Straub, V., Talim, B., Voit, T., Topaloglu, H., Toda, T., and Endo, T. (2001) Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev. Cell 1, 717-724
21. Beltran-Valero de Bernabé, D., Voit, T., Longman, C., Steinbrecher, A., Straub, V., Yuva, Y., Herrmann, R., Sperner, J., Korenke, C., Diesen, C., Dobyns, W. B., Brunner, H. G., van Bokhoven, H., Brockington, M., and Muntoni, F. (2004) Mutations in the FKRP gene can cause muscle-eyebrain disease and Walker-Warburg syndrome. J. Med. Genet. 41, e61
22. Yoshida-Moriguchi, T., Yu, L., Stalnaker, S. H., Davis, S., Kunz, S., Madson, M., Oldstone, M. B., Schachter, H., Wells, L., and Campbell, K. P. (2010) O-mannosyl phosphorylation of α-dystroglycan is required for laminin binding. Science 327, 88-92
23. Inamori, K., Yoshida-Moriguchi, T., Hara, Y., Anderson, M. E., Yu, L., and Campbell, K. P. (2012) Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE. Science 335, 93-96
24. Barresi, R., Michele, D. E., Kanagawa, M., Harper, H. A., Dovico, S. A., Satz, J. S., Moore, S. A., Zhang, W., Schachter, H., Dumanski, J. P., Cohn, R. D., Nishino, I., and Campbell, K. P. (2004) LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies. Nat. Med. 10, 696-703
25. Grewal, P. K., and Hewitt, J. E. (2002) Mutation of Large, which encodes a putative glycosyltransferase, in an animal model of muscular dystrophy. Biochim. Biophys. Acta. 1573, 216-224
26. Grewal, P. K., McLaughlan, J. M., Moore, C. J., Browning, C. A., and Hewitt, J. E. (2005) Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies. Glycobiology 15, 912-923
27. Fujimura, K., Sawaki, H., Sakai, T., Hiruma, T., Nakanishi, N., Sato, T., Ohkura, T., and Narimatsu, H. (2005) LARGE2 facilitates the maturation of α-dystroglycan more effectively than LARGE. Biochem. Biophys. Res. Commun. 329, 1162-1171
28. Durbeej, M., Larsson, E., Ibraghimov-Beskrovnaya, O., Roberds, S. L., Campbell, K. P., and Ekblom, P. (1995) Non-muscle α-dystroglycan is involved in epithelial development. J. Cell Biol. 130, 79-91
29. Deng, W. M., Schneider, M., Frock, R., Castillejo-Lopez, C., Gaman, E. A., Baumgartner, S., and Ruohola-Baker, H. (2003) Dystroglycan is required for polarizing the epithelial cells and the oocyte in Drosophila. Development 130, 173-184
30. Weir, M. L., Oppizzi, M. L., Henry, M. D., Onishi, A., Campbell, K. P., Bissell, M. J., and Muschler, J. L. (2006) Dystroglycan loss disrupts polarity and {β}-casein induction in mammary epithelial cells by perturbing laminin anchoring. J. Cell Sci. 119, 4047-4058
31. Esser, A. K., Cohen, M. B., and Henry, M. D. (2010) Dystroglycan is not required for maintenance of the luminal epithelial basement membrane or cell polarity in the mouse prostate. Prostate 70, 777-787
32. Jarad, G., Pippin, J. W., Shankland, S. J., Kreidberg, J. A., and Miner, J. H. (2011) Dystroglycan does not contribute significantly to kidney develop- ment or function, in health or after injury. Am. J. Physiol. Renal Physiol. 300, F811-F820
33. Mirouse, V., Christoforou, C. P., Fritsch, C., St Johnston, D., and Ray, R. P. (2009) Dystroglycan and perlecan provide a basal cue required for epithelial polarity during energetic stress. Dev. Cell 16, 83-92
34. Muschler, J., Levy, D., Boudreau, R., Henry, M., Campbell, K., and Bissell, M. J. (2002) A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res. 62, 7102-7109
35. Bao, X., Kobayashi, M., Hatakeyama, S., Angata, K., Gullberg, D., Nakayama, J., Fukuda, M. N., and Fukuda, M. (2009) Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3-N- acetylglucosaminyltransferase. Proc. Natl. Acad. Sci. U.S.A. 106, 12109-12114
36. Sgambato, A., Camerini, A., Faraglia, B., Pavoni, E., Montanari, M., Spada, D., Losasso, C., Brancaccio, A., and Cittadini, A. (2004) Increased expression of dystroglycan inhibits the growth and tumorigenicity of human mammary epithelial cells. Cancer Biol. Ther. 3, 967-975
37. Higginson, J. R., and Winder, S. J. (2005) Dystroglycan: a multifunctional adaptor protein. Biochem. Soc. Trans. 33, 1254-1255
38. Henry, M. D., Cohen, M. B., and Campbell, K. P. (2001) Reduced expression of dystroglycan in breast and prostate cancer. Hum. Pathol. 32, 791-795
39. Sgambato, A., Migaldi, M., Montanari, M., Camerini, A., Brancaccio, A., Rossi, G., Cangiano, R., Losasso, C., Capelli, G., Trentini, G. P., and Cittadini, A. (2003) Dystroglycan expression is frequently reduced in human breast and colon cancers and is associated with tumor progression. Am. J. Pathol. 162, 849-860
40. Singh, J., Itahana, Y., Knight-Krajewski, S., Kanagawa, M., Campbell, K. P., Bissell, M. J., and Muschler, J. (2004) Proteolytic enzymes and altered glycosylation modulate dystroglycan function in carcinoma cells. Cancer Res. 64, 6152-6159
41. de Bernabé, D. B., Inamori, K., Yoshida-Moriguchi, T., Weydert, C. J., Harper, H. A., Willer, T., Henry, M. D., and Campbell, K. P. (2009) Loss of α-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE. J. Biol. Chem. 284, 11279-11284
42. Shang, Z. J., Ethunandan, M., Górecki, D. C., and Brennan, P. A. (2008) Aberrant expression of α-dystroglycan may be due to processing by matrix metalloproteinases-2 and -9 in oral squamous cell carcinoma. Oral oncology 44, 1139-1146
43. Svensson, R. U., Barnes, J. M., Rokhlin, O. W., Cohen, M. B., and Henry, M. D. (2007) Chemotherapeutic agents up-regulate the cytomegalovirus promoter: implications for bioluminescence imaging of tumor response to therapy. Cancer Res. 67, 10445-10454
44. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45
45. Drake, J. M., Barnes, J. M., Madsen, J. M., Domann, F. E., Stipp, C. S., and Henry, M. D. (2010) ZEB1 coordinately regulates laminin-332 and {β}4 integrin expression altering the invasive phenotype of prostate cancer cells. J. Biol. Chem. 285, 33940-33948
46. Sgambato, A., De Paola, B., Migaldi, M., Di Salvatore, M., Rettino, A., Rossi, G., Faraglia, B., Boninsegna, A., Maiorana, A., and Cittadini, A. (2007) Dystroglycan expression is reduced during prostate tumorigenesis and is regulated by androgens in prostate cancer cells. J. Cell. Physiol. 213, 528-539
47. Shimojo, H., Kobayashi, M., Kamigaito, T., Shimojo, Y., Fukuda, M., and Nakayama, J. (2011) Reduced glycosylation of α-dystroglycans on carcinoma cells contributes to formation of highly infiltrative histological patterns in prostate cancer. Prostate 71, 1151-1157
48. Epstein, J. I., Allsbrook, W. C., Jr., Amin, M. B., and Egevad, L. L. (2005) The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am. J. Surg. Pathol. 29, 1228-1242
49. Gleason, D. F., and Mellinger, G. T. (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J. Urol. 111, 58-64
50. Drake, J. M., Strohbehn, G., Bair, T. B., Moreland, J. G., and Henry, M. D. (2009) ZEB1 enhances transendothelial migration and represses the epithelial phenotype of prostate cancer cells. Mol. Biol. Cell 20, 2207-2217
51. Yoneyama, T., Angata, K., Bao, X., Courtneidge, S., Chanda, S. K., and Fukuda, M. (2012) Fer kinase regulates cell migration through α-dystroglycan glycosylation. Mol. Biol. Cell 23, 771-780
52. Edge, S. B., and American Joint Committee on Cancer. (2010) AJCC Cancer Staging Manual, 7th ed., Springer, New York
53. Sgambato, A., Tarquini, E., Resci, F., De Paola, B., Faraglia, B., Camerini, A., Rettino, A., Migaldi, M., Cittadini, A., and Zannoni, G. F. (2006) Aberrant expression of α-dystroglycan in cervical and vulvar cancer. Gynecol. Oncol. 103, 397-404
54. Sgambato, A., Camerini, A., Amoroso, D., Genovese, G., De Luca, F., Cecchi, M., Migaldi, M., Rettino, A., Valsuani, C., Tartarelli, G., Donati, S., Siclari, O., Rossi, G., and Cittadini, A. (2007) Expression of dystroglycan correlates with tumor grade and predicts survival in renal cell carcinoma. Cancer Biol. Ther. 6, 1840-1846
55. Calogero, A., Pavoni, E., Gramaglia, T., D'Amati, G., Ragona, G., Brancaccio, A., and Petrucci, T. C. (2006) Altered expression of α-dystroglycan subunit in human gliomas. Cancer Biol. Ther. 5, 441-448
56. Martin, L. T., Glass, M., Dosunmu, E., and Martin, P. T. (2007) Altered expression of natively glycosylated α-dystroglycan in pediatric solid tumors. Hum. Pathol. 38, 1657-1668
57. Shen, J. G., Xu, C. Y., Li, X., Dong, M. J., Jiang, Z. N., Wang, J., and Wang, L. B. (2012) Dystroglycan is associated with tumor progression and patient survival in gastric cancer. Pathol. Oncol. Res. 18, 79-84
58. Sgambato, A., Caredda, E., Leocata, P., Rossi, G., Boninsegna, A., Vitale, A., Grandi, T., Cittadini, A., and Migaldi, M. (2010) Expression of α-dystroglycan correlates with tumour grade and predicts survival in oral squamous cell carcinoma. Pathology 42, 248-254
59. Jiang, X., Rieder, S., Giese, N. A., Friess, H., Michalski, C. W., and Kleeff, J. (2011) Reduced α-dystroglycan expression correlates with shortened patient survival in pancreatic cancer. J. Surg. Res. 171, 120-126
60. Moon, Y. W., Rha, S. Y., Zhang, X., Jeung, H. C., Yang, W. I., Kwon, O., Jeong, J. H., Cheon, S. H., Yoo, N. C., and Chung, H. C. (2009) Increments of α-dystroglycan expression in liver metastasis correlate with poor survival in gastric cancer. J. Surg. Oncol. 100, 459-465